Skip to main content

Table 3 Baseline characteristic of patients before IST based on serum Apo-A level

From: Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study

Characteristic

All (n = 61)

Hyper-Apo-A (n = 18)

Hypo-Apo-A (n = 43)

Sig (P value)

Age (years): median (range)

28.0(10–57)

21.5(10–56)

29.0(13–57)

0.015

Gender (male/female)

29/32

8/10

21/22

0.786

BMI (weight/hight^2): median (range)

22.2(17.69–26.95)

22.27(22.27–24.80)

21.41(17.69–26.96)

0.517

SAA/VSAA

40/21

11/7

29/14

0.769

Duration (diagnose to IST, days): median (range)

33.0(5–149)

34.5(13–98)

27.0(5–149)

0.452

WBC (10^9/L, \(\overline{\mathrm X}\) ± s)

1.27 ± 0.59

1.20 ± 0.42

1.31 ± 0.65

0.769

ANC (10^9/L, \(\overline{\mathrm X}\) ± s)

0.26 ± 0.15

0.24 ± 0.17

0.27 ± 0.14

0.620

RBC (10^12/L, \(\overline{\mathrm X}\) ± s)

1.95 ± 0.46

2.06 ± 0.36

1.91 ± 0.49

0.116

HB (g/dL)

59.50 ± 10.87

60.89 ± 10.86

58.91 ± 10.95

0.261

PLT (10^9/L, \(\overline{\mathrm X}\) ± s)

7.31 ± 4.16

6.39 ± 3.50

7.70 ± 4.40

0.396

Ret (10^10/L, \(\overline{\mathrm X}\) ± s)

1.74 ± 1.38

1.55 ± 1.13

1.82 ± 1.47

0.486